Vonoprazan-based quadruple therapy is non-inferior to esomeprazole-based quadruple therapy for Helicobacter pylori eradication: A multicenter, double-blind, randomized, phase 3 study

Authors

Shingo Kuroda (ORCID: https://orcid.org/0000-0001-7672-4214)
Liya Zhou (ORCID: https://orcid.org/0000-0002-2064-5522)
Liqun Gu
Fei Liu (ORCID: https://orcid.org/0000-0003-3684-0944)
Zhenyu Zhang (ORCID: https://orcid.org/0000-0002-1523-0672)
Guoxin Zhang (ORCID: https://orcid.org/0000-0002-4475-1848)
Nonghua Lü (ORCID: https://orcid.org/0000-0003-4373-551X)
Zhiqiang Song (ORCID: https://orcid.org/0000-0003-0976-419X)
Qin Du (ORCID: https://orcid.org/0000-0002-2387-913X)

Institutions

Nanchang University (CN)
Peking University (CN)
Shanghai East Hospital (CN)
Peking University Third Hospital (CN)
Jiangsu Province Hospital (CN)
Second Affiliated Hospital of Zhejiang University (CN)
First Affiliated Hospital of Nanchang University (CN)
Takeda (Japan) (JP)
Nanjing Medical University (CN)

Publication Details

Journal: Chinese Medical Journal
Published: 2025-02-18
DOI: https://doi.org/10.1097/cm9.0000000000003437
Citations: 3
Primary Topic: Helicobacter pylori-related gastroenterology studies
Type: article
Field-Weighted Citation Impact: 6.02

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Vonoprazan-based quadruple therapy is non-inferior to esomeprazole-based quadruple therapy for Helicobacter pylori eradication: A multicenter, double-blind, randomized, phase 3 study

Shingo Kuroda, Liya Zhou, Liqun Gu, Fei Liu et al.

Feb 18, 2025

3 citations

Chinese Medical Journal

Helicobacter pylori-related gastroenterology studies

6.02

article

Vonoprazan-based quadruple therapy is non-inferior to esomeprazole-based quadruple therapy for Helicobacter pylori eradication: A multicenter, double-blind, randomized, phase 3 study

Shingo Kuroda, Liya Zhou, Liqun Gu, Fei Liu, Zhenyu Zhang, Guoxin Zhang, Nonghua Lü, Zhiqiang Song, Qin Du

February 18, 2025article en

3 citations

Abstract

No abstract available for this paper.

Chinese Medical JournalVol. 138(22)

Nanchang University (CN), Peking University (CN), Shanghai East Hospital (CN), Peking University Third Hospital (CN), Jiangsu Province Hospital (CN), Second Affiliated Hospital of Zhejiang University (CN), First Affiliated Hospital of Nanchang University (CN), Takeda (Japan) (JP), Nanjing Medical University (CN)

Good health and well-being

Openalex Percentile: Top 5%

Helicobacter pylori-related gastroenterology studies

6.02

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Vonoprazan-based quadruple therapy is non-inferior to esomeprazole-based quadruple therapy for Helicobacter pylori eradication: A multicenter, double-blind, randomized, phase 3 study — Shingo Kuroda, Liya Zhou, et al. · Chinese Medical Journal (2025) | TGRS Research Map | TGRS